Syndicated Research Studies

The global  pharmaceutical glass packaging market  size is expected to reach USD 37.62 billion by 2030, registering a CAGR of 9.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The factors expected to drive the growth are the high recyclability of the glass, chemical inertness, increasing developments in the pharmaceutical industry, and the growing demand for vials for COVID vaccines. The pharmaceutical industry is witnessing a significant transition and over the past few years, the focus on the development of pharmaceutical drugs has grown significantly. The growing research environment in emerging economies such as India, China, and Brazil has led to a gradual migration of economic and research activities from developed markets to these emerging markets. Since 2006, the United Nations Industrial Development Organization has provided advisory services and technical cooperation to develop local pharmaceutical production in developing countries. Thi...

Pharmaceutical Glass Packaging Industry Overview The global pharmaceutical glass packaging market size was valued at USD 3.79 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.8% from 2021 to 2028. Extensive utilization of generic injectable drugs, coupled with the high demand from the pharmaceutical industry, is anticipated to drive the market. Glass poses as a hindrance to atmospheric gases, such as carbon dioxide and oxygen, from entering the primary container, mitigating the risk of contamination of the drugs. Glass packaging lowers the drug’s susceptibility to degradation, such as hydrolysis and oxidation. Moreover, glass packaging helps in resisting the escape of volatile ingredients, thereby increasing the drug stability. All these factors are anticipated to surge the product demand in the near future. The growth in the global pharma market slowed considerably in 2017 due to the slow growth of the industry in emerg...